Patients
Precision medicine in action, with Cary Claiborne
Cary Claiborne, CEO of Adial Pharmaceuticals, discusses his company’s bet on a precision treatment for AUD.
Patients
On addressing drug waste and ensuring access, with Jeff Harp...
The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.
R&D
AMR and vaccines: Can universal coverage avert a post-antibi...
Antimicrobial resistance (AMR) is a growing global health crisis.
Patients
Sponsored
From insight to impact: Why the patient voice will redefine ...
Is patient-centred trial design becoming a strategic advantage for mid-size pharma, helping cut risk, improve timelines, and engage patients?
R&D
Treating the chronic diseases GLP-1s miss, with Laurent Auda...
Prive Bio CEO Laurent Audaly spoke with pharmaphorum during the JP Morgan Healthcare conference, discussing GLP-1s in the cardiometabolic space.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
